Author:
UNVERZAGT FREDERICK W.,MORGAN OWEN S.,THESIGER CHARLES H.,ELDEMIRE DENISE A.,LUSEKO JOHN,POKURI SARADA,HUI SIU L.,HALL KATHLEEN S.,HENDRIE HUGH C.
Abstract
Information on the clinical utility of neuropsychological
tests in non-North-American samples is limited. We examined
the diagnostic efficacy of the Consortium to Establish
a Registry for Alzheimer's Disease (CERAD) neuropsychological
battery in Jamaican men and women age 65 and older. A total
of 72 elders were diagnosed as normal and 12 were demented
based on history, physical, and neurological examination.
Independent of this medical examination, participants were
tested with the CERAD battery. Normal controls scored significantly
better than dementia patients on all tests in the CERAD
battery. A discriminant function found that a combination
of Word List Learning Sum Recall and Boston Naming Test
correctly classified a total of 81% of the cases (83% of
the dements and 81% of the normal controls). This study
is the first to demonstrate the clinical utility of the
CERAD neuropsychological battery in the differential diagnosis
of memory disorders of the aged in a non-North-American
sample. (JINS, 1999, 5, 255–259.)
Publisher
Cambridge University Press (CUP)
Subject
Psychiatry and Mental health,Clinical Neurology,Clinical Psychology,General Neuroscience
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献